Predictive Model for Early Neurological Deterioration in Acute Ischemic Stroke Utilizing Novel Thrombotic Biomarkers
Brain and Behavior · 2025-05 · 15 (5)
DOI: 10.1002/brb3.70577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 26.05.2025. Verfasst von Yifei Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xianyang Hospital of Yan' an University, Xianyang, China. Hauptthemen laut MEDLINE: Ischemic Stroke, Thrombosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xianyang Hospital of Yan' an University.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Novel thrombotic molecular markers are significantly linked to acute ischemic stroke (AIS). However, the relationship between thrombin‐antithrombin complex (TAT), tissue plasminogen activator–inhibitor complex (t‐PAIC), plasmin‐α2 plasmin inhibitor complex (PIC), thrombomodulin (TM), and early neurological deterioration (END) remains unclear. Therefore, we developed a prediction model for END based on these markers and evaluated its accuracy and clinical utility.
Methods
Retrospective analysis of patients diagnosed with AIS in our hospital from 2023–2024. The above patients were divided into a training set (N = 577) and a test set (N = 246) in a 7:3 ratio. Least absolute shrinkage and selection of operator regression (LASSO) valid predictors were used. The coefficients of the predictors in logistic regression were used to develop a nomogram and to validate its differentiation, calibration, and clinical utility.
Results
The prevalence of END in AIS patients was 24.3%. Predictors screened according to LASSO regression analysis included age, the National Institutes of Health Stroke Scale (NIHSS) score, t‐PAIC, PIC, lymphocyte, and platelet. The resulting nomograms had the area under the curve (AUC) of 0.867 (95% CI, 0.834‐0.9) and 0.825 (95% CI, 0.757‐0.892) in the training and test sets, respectively, which had good differentiation. In addition, the calibration curve and decision curve analysis (DCA) showed that the model had good calibration and clinical utility.
Conclusion
A predictive model for END was developed using the serological markers t‐PAIC (male >17.13 ng/mL;female >10.52 ng/mL), PIC >0.85 µg/mL, Lymph ≤ 3.2×10^9/L, NIHSS, age, and platelet. The model has significant predictive value for END occurrence in patients with AIS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Xianyang Hospital of Yan' an University, Xianyang, China.
- Department of Neurology, The First People's Hospital of Xianyang, Xianyang, China.
- Department of Neurological Intensive Care Unit, Xianyang Hospital of Yan'an University, Xianyang, China.
- Institute of Brain Disease, Xianyang Hospital of Yan'an University, Xianyang, China.
ORCID-Profile: Ping Chen
Förderung
- Xianyang Hospital of Yan' an University
Zitieren
APA
Zhao, Y., Zhu, H., Dai, C., Liu, W., Yu, W., Yan, B., Ji, X., Li, L., Wei, D., Li, Z., & Chen, P. (2025). Predictive Model for Early Neurological Deterioration in Acute Ischemic Stroke Utilizing Novel Thrombotic Biomarkers. Brain and Behavior, 15(5). https://doi.org/10.1002/brb3.70577
Vancouver
Zhao Y, Zhu H, Dai C, Liu W, Yu W, Yan B, et al. Predictive Model for Early Neurological Deterioration in Acute Ischemic Stroke Utilizing Novel Thrombotic Biomarkers. Brain and Behavior. 2025;15(5). doi:10.1002/brb3.70577
BibTeX
@article{Zhao2025,
author = {Zhao, Yifei and Zhu, Hao and Dai, Changfei and Liu, Wen and Yu, Wenjin and Yan, Bin and Ji, Xiyang and Li, Lin and Wei, Dong and Li, Zhaopan and Chen, Ping},
title = {Predictive Model for Early Neurological Deterioration in Acute Ischemic Stroke Utilizing Novel Thrombotic Biomarkers},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {5},
doi = {10.1002/brb3.70577}
}
EUVIMED